| Product Name | Lorlatinib - API |
| Product Code | DA-L162-a |
| Chemical name | Lorlatinib |
| Synonyms | (R)-26-Amino-55-fluoro-11,4,7-trimethyl-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile; (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile; |
| Impurity | NA |
| CAS Number | 1454846-35-5 |
| Alternate CAS # | NA |
| Molecular form | C21H19FN6O2 |
| Appearance | White Solid |
| Melting Point | NA |
| Mol. Weight | 406.42 |
| Storage | 2-8°C Hygroscopic, Refrigerator, Under inert atmosphere |
| Solubility | NA |
| Stability | NA |
| Category | pharmaceutical standards,impurities,intermediates,metabolites,fine chemicals |
| Boiling Point | NA |
| Applications | PF- 06463922 is a potent and selective ROS1/ALK inhibitor capable to block crizotinib-resistant ROS1 mutations. Used in the treatment of human cancers. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
